Daratumumab Phase 3 Study: Phase 3 Randomized Study Of Daratumumab + Bortezomib:Thalidomide:Dexamethasone (D-VTd) VS VTd In Transplant-Eligible NDMM
Philippe Moreau, MD Of Nantes Faculty of Medicine Discusses Daratumumab Phase 3 Study: Phase 3 Randomized Study Of Daratumumab + Bortezomib:Thalidomide:Dexamet​hasone (D-VTd) VS VTd In Transplant-Eligi...
Author: Annual-Meeting
Added: 06/02/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts